Sino-atrial block during anesthesia in a patient with breast cancer being treated with the anticancer drug epirubicin

Anesthesia and Analgesia

Volumn 97, Issue 1, 2003, Pages 19-20

  Okamoto, Takashi ^a   Ogata, Junichi ^a   Minami, Kouichiro ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIRUBICIN;

ADULT; ANESTHESIA; ANESTHESIST; ARTICLE; ARTIFICIAL HEART PACEMAKER; BREAST CANCER; CARDIOTOXICITY; CASE REPORT; ECG ABNORMALITY; FEMALE; HEART SINOATRIAL BLOCK; HUMAN; PRIORITY JOURNAL;

EID: 0038311874     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000067680.26469.2b     Document Type: Article

References (7)

1. Della Torre P, Podesta A, Pinciroli G, et al. Long-lasting effect of dexrazoxane against anthracycline cardiotoxicity in rats. Toxicol Pathol 1996;24:398-402.
2. Doroshow JH. Doxorubicin-induced cardiac toxicity. N Engl J Med 1991;324:843-5.
3. 2+ release channel from rat cardiac sarcoplasmic reticulum: possible receptor-mediated mechanism of doxorubicin cardiomyopathy. Mol Pharmacol 1990;37:503-14.
4. Olson RD, Mushlin PS, Brenner DE, et al. Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol. Proc Natl Acad Sci U S A 1988;85:3585-9.
5. Robert J. Epirubicin: clinical pharmacology and dose-effect relationship. Drugs 1993;45:20-30.
6. Villani F, Comazzi R, Lacaita G, et al. Preliminary echocardiographic and polygraphic evaluation of cardiac toxicity of 4′-epidoxorubicin. Int J Clin Pharmacol Ther Toxicol 1983;21:203-8.
7. Lanza E, Rozza A, Favalli L, et al. The rat model in the comparative evaluation of anthracyclines cardiotoxicity. Tumori 1989;75: 533-6.